Lombard touts 5-year Aorfix stent graft data
Lombard Medical Technologies (NSDQ:EVAR) yesterday released 5-year results from the Pythagoras trial of its Aorfix, which aimed to evaluate the safety and effectiveness of the stent graft in treating highly angulated aortic necks or tortuous aortoiliac anatomy.
A presentation based on data from the study was presented at the 2016 Society for Vascular Surgery’s annual meeting in National Harbor, Maryland this week, the company said.
A total of 87% of surviving patients in the 218 patient trial were followed-up with at 5 years, Lombard said, with 60% of angled neck patients showing significant aneurysm sac shrinkage. ...
Source: Mass Device - June 14, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Vascular Lombard Medical Source Type: news
Endovascular Grafts for Abdominal Aortic AneurysmEndovascular Grafts for Abdominal Aortic Aneurysm
This paper reviews the current best practice and evidence for endovascular aortic repair and stenting in abdominal aortic aneurysm. What issues remain unresolved? European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 16, 2016 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
Medtronic touts Endurant AAA graft 4-year data
Medtronic (NYSE:MDT) said today that 4-year real world data from a subset of patients with challenging anatomy implanted with the Endurant AAA stent graft system showed durable outcomes. The data was presented at the VEITHsymposium in New York City.
At 4-years, no differences in IA endoleak rate or AAA diameter increases were found between subsets of patients with short necks and standard necks, the company said, and freedom from aneurysm-related mortality was 99.2% for the short neck cohort and 98.3% for standard length neck patients.
“Analysis of the patient cohort from the 4-year global Engage registry included ...
Source: Mass Device - November 17, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Stent Grafts Vascular Medtronic Source Type: news
Medtronic Touts Four-Year Stent Graft Outcomes
Selected for nearly one of every two endovascular abdominal aortic aneurysm (AAA) repairs globally, the EndurantAAA stent graft system from Medtronic plc continues to maintain durable and consistent outcomes at four years in real world settings, including challenging anatomies, according to a presentation byHence J.M. Verhagen, M.D., Ph.D., Professor and Chief of Vascular Surgery, Erasmus University Medical Center in Rotterdam, the Netherlands, on the opening day of the VEITH symposium in New York City. (Source: Medical Design Online News)
Source: Medical Design Online News - November 17, 2015 Category: Medical Equipment Source Type: news
Endologix, TriVascular Technologies ink $211m merger
Endologix (NSDQ:ELGX) and TriVascular Technologies (NSDQ:TRIV) yesterday said they plan to merge in a cash-and-stock deal worth $211 million.
If consummated, the deal would unite 2 of the stent graft market’s smaller players. Both companies makes devices for treating abdominal aortic aneurysms; Irvine, Calif.-based Endologix makes 2 lines of stent grants, the Nellix and AFX devices, while Santa Rosa, Calif.-based TriVascular makes the Ovation stent graft.
The deal, which values TriVascular at $9.10 per share, calls for TRIV shareholders to receive a to-be-determined combination of ELGX shares and cash equal to ...
Source: Mass Device - October 27, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: MassDevice Earnings Roundup Stent Grafts Endologix Inc. TriVascular Source Type: news
Lombard Medical Names David Milne to Board of Directors
IRVINE, Calif., Sept. 8, 2015 -- (Healthcare Sales & Marketing Network) -- Lombard Medical Inc. (EVAR), a medical device company focused on endovascular aortic repair of abdominal aortic aneurysms, today announced that medical device executive and investor... Devices, Interventional, PersonnelLombard Medical, Aorfix, abdominal aortic aneurysm, AAA (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 8, 2015 Category: Pharmaceuticals Source Type: news
Endovascular Aortic Aneurysm Repair May Have Trade-offsEndovascular Aortic Aneurysm Repair May Have Trade-offs
Compared with open repair, mortality rates were lower for patients with endovascular repair through the third year of follow-up, when the pattern shifted. Medscape Medical News (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - September 4, 2015 Category: Surgery Tags: General Surgery News Source Type: news
Lombard purchases endograft developer Altura
Lombard Medical Technologies (NSDQ:EVAR) said today it acquired endovascular stent graft developer Altura Medical.
Altura develops ultra-low profile endovascular stent graft technology intended for the treatment of abdominal aortic aneurysms, in line with Lombard’s own technologies and their flagship Aorfix endograft.
The terms of the transaction between Irvine, Calif.-based Lombard and Silicon Valley-based Altura medical included the issuance of $15 million of Lombard stock at $4 per share, the assumption of $5.5 million in debt and $2.5 million in liabilities and transaction related costs, Lombard said.
“Th...
Source: Mass Device - July 30, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Mergers & Acquisitions Stent Grafts Altura Medical Devices Lombard Medical Technologies Source Type: news
Lombard Medical looks to M&A to grow beyond AorFix
Lombard Medical Technologies (NSDQ:EVAR) CEO Simon Hubbert this week said the stent graft maker is looking beyond the abdominal aortic aneurysm repair market, aiming to grow out of being a 1-product company either via acquisition or a distribution deal with a larger medical device company.
Discussing Lombard’s 2nd-quarter results July 27, Hubbert referenced the $110 million buyout of Aptus Endosystems by Medtronic (NYSE:MDT) last month, observing that the crowded and competitive abdominal aortic aneurysm repair market is driving consolidation.
“We believe this environment presents us with the opportunit...
Source: Mass Device - July 29, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: MassDevice Earnings Roundup Mergers & Acquisitions Stent Grafts Lombard Medical Source Type: news
Essential Medical launches Manta device trial
Essential Medical said today it launched a clinical study of its Manta large bore vascular closure device.
The Manta system is designed to close large bore punctures following procedures like transcatheter aortic valve replacements, abdominal aortic aneurysm repairs and balloon aortic valvuplasty, the Malvern, Penn.-based company said. Essential Medical said the device is designed to close punctures in less than 1 minute and provides immediate hemostasis.
The study will examine patients treated with the Manta device following TAVR procedures, the company said. In initial patients, the Manta device was deployed in less than...
Source: Mass Device - July 27, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Cardiovascular Clinical Trials Surgical Essential Medical Devices Source Type: news
Confirmed: Early Benefit for Endovascular AAA Repair Fades with Time (CME/CE)
(MedPage Today) -- Long-term survival in aortic aneurysm patients the same as with open repair (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - July 24, 2015 Category: Cardiology Source Type: news
Less-Invasive Repair of Aortic Aneurysm Better in Short Term: Study
But survival advantage it showed in fixing bulging, weak spot diminished over time (Source: WebMD Health)
Source: WebMD Health - July 22, 2015 Category: Consumer Health News Source Type: news
Less-Invasive Repair of Aortic Aneurysm Better in Short Term
But survival advantage it showed in fixing bulging, weak spot diminished over time
Source: HealthDay
Related MedlinePlus Pages: Aortic Aneurysm, Surgery (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - July 22, 2015 Category: Consumer Health News Source Type: news
Medtronic touts 5-year Endurant AAA stent data
Medtronic (NYSE:MDT) said its Endurant abdominal aortic aneurysm stent is performing well, according to a 5-year follow-up study of the device. The announcement was made at the Society for Vascular Surgery’s annual meeting in Chicago last Saturday.
The 5-year, 150-patient study data reported a 99.2% freedom from aneurysm related mortality and an 89% freedom from secondary endovascular interventions, the Fridley, Minn.-based company said.
“The 5-year results from this study reinforce the long-term durability and consistency of the clinical outcomes that vascular specialists around the world have experienced wit...
Source: Mass Device - June 22, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Stent Grafts Stents Vascular medtronic Source Type: news
